Biomarkers for Cystic Fibrosis Drug Development

PURPOSE: To provide a review of the status of biomarkers in cystic fibrosis drug development, including regulatory definitions and considerations, a summary of biomarkers in current use with supportive data, current gaps, and future needs. METHODS: Biomarkers are considered across several areas of C...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Cyst Fibros
Main Authors: Muhlebach, Marianne S., Clancy, JP, Heltshe, Sonya L., Ziady, Assem, Kelley, Tom, Accurso, Frank, Pilewski, Joseph, Mayer-Hamblett, Nicole, Joseloff, Elizabeth, Sagel, Scott D.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5321565/
https://ncbi.nlm.nih.gov/pubmed/28215711
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcf.2016.10.009
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados